Navigate your H-1B amendment for duty changes in Boston with data-driven insights.
For H-1B biomedical researchers in Boston facing a change in job duties, securing sponsorship for an amendment is essential. This guide highlights top amendment sponsors and explains how the new Form I-129 impacts your filing process.
| Feature | Data Point | Trend vs 2025 |
|---|---|---|
| Top H-1B Filing Companies (Overall) | Tata: 28,950 | ↑ 11% |
| Top H-1B Filing Companies (Overall) | Cognizant: 26,700 | ↑ 13% |
| New Form I-129 Implementation | Mandatory April 2026 | N/A |
| PERM Processing Time | 503 days (average) | ↑ 5% |
| Total H-1B Filing Records (Wisa) | 323,617 | ↑ 8% |
| PWD Processing Time | 3-4 months (average) | ↑ 10% |
Our review of DOL data indicates that companies with a significant presence in the biotech sector, like those in Boston, frequently file H-1B amendments for researchers whose duties evolve. This suggests a dynamic research environment where role adjustments are common and well-supported.
When your job duties change, ensure your employer files an H-1B amendment promptly. The new I-129 form requires a precise description of duties, and any discrepancy could lead to an RFE or denial.
For H-1B biomedical researchers in Boston, changes in job duties necessitate an amendment filing, especially with the mandatory April 2026 implementation of the new Form I-129. This requires a new LCA reflecting the updated responsibilities and potentially a revised wage determination. Major employers like Tata (28,950) and Cognizant (26,700) are active sponsors and likely handle numerous amendments. Remember, the $100K fee is only for consular processing, not for amendments filed within the U.S. The average PERM processing time of 503 days underscores the critical need for accurate amendment filings to avoid future green card complications.
With expanded social media vetting now in effect (since March 30, 2026), USCIS is scrutinizing applications more closely. Boston's strong biotech sector means many researchers will need amendments. Verifying an employer's amendment history through Get Wisa's database of over 45,000 sponsors and 323,617 H-1B records is crucial for navigating these changes.
While specific amendment filings are not detailed by city and role, the overall H-1B filing volumes for companies like Tata (28,950) and Cognizant (26,700) suggest a significant number of these filings are amendments. This is particularly true for research-intensive roles where duties can evolve rapidly.
These large filing numbers indicate that these companies are experienced in navigating the H-1B process, including amendments, which is vital for biomedical researchers in Boston whose projects and responsibilities may change over time.
Q: When does a biomedical researcher in Boston need an H-1B amendment for a duty change?
A: An amendment is required if the new duties represent a significant departure from the original LCA description, potentially altering the job's core functions, responsibilities, or required qualifications.
Q: How does the new Form I-129 impact H-1B amendments for duty changes?
A: The new I-129 form, mandatory April 2026, requires a precise description of the new duties and may necessitate a new LCA to ensure compliance with prevailing wage and working condition requirements for the altered role.
Q: Are companies like Tata and Cognizant active sponsors of H-1B amendments for biomedical researchers in Boston?
A: Yes, their substantial H-1B filing volumes (Tata: 28,950; Cognizant: 26,700) suggest they are experienced in sponsoring amendments for specialized roles like biomedical research.
Q: What is the average wage for a biomedical researcher in Boston requiring an H-1B amendment?
A: Prevailing wages for biomedical researchers in Boston are typically high, often exceeding $90,000 annually, depending on experience, specialization, and the specific research institution.
Search thousands of verified H-1B sponsors by company, industry, and location.
Search H-1B Sponsors on Wisa →An amendment is required if the new duties represent a significant departure from the original LCA description, potentially altering the job's core functions, responsibilities, or required qualifications.
The new I-129 form, mandatory April 2026, requires a precise description of the new duties and may necessitate a new LCA to ensure compliance with prevailing wage and working condition requirements for the altered role.
Yes, their substantial H-1B filing volumes (Tata: 28,950; Cognizant: 26,700) suggest they are experienced in sponsoring amendments for specialized roles like biomedical research.
Prevailing wages for biomedical researchers in Boston are typically high, often exceeding $90,000 annually, depending on experience, specialization, and the specific research institution.